Biohaven (BHVN) Competitors

Biohaven (NYSE:BHVN) and Elanco Animal Health (NYSE:ELAN) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, earnings, media sentiment, dividends, community ranking, analyst recommendations, valuation, risk and profitability.

Is BHVN or ELAN more profitable?

Elanco Animal Health has a net margin of 4.60% compared to Biohaven's net margin of 0.00%. Elanco Animal Health's return on equity of 6.78% beat Biohaven's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Biohaven	N/A	-225.12%	-158.89%
Elanco Animal Health	4.60%	6.78%	3.03%

Does the media refer more to BHVN or ELAN?

In the previous week, Biohaven had 4 more articles in the media than Elanco Animal Health. MarketBeat recorded 7 mentions for Biohaven and 3 mentions for Elanco Animal Health. Elanco Animal Health's average media sentiment score of 0.00 beat Biohaven's score of -0.05 indicating that Elanco Animal Health is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Biohaven	1 Very Positive mention(s)	0 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Elanco Animal Health	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Does the MarketBeat Community prefer BHVN or ELAN?

Biohaven received 266 more outperform votes than Elanco Animal Health when rated by MarketBeat users. Likewise, 67.43% of users gave Biohaven an outperform vote while only 54.96% of users gave Elanco Animal Health an outperform vote.

Company	Underperform	Outperform
Biohaven	Outperform Votes 410 67.43%	Underperform Votes 198 32.57%
Elanco Animal Health	Outperform Votes 144 54.96%	Underperform Votes 118 45.04%

Which has stronger earnings & valuation, BHVN or ELAN?

Biohaven has higher earnings, but lower revenue than Elanco Animal Health. Biohaven is trading at a lower price-to-earnings ratio than Elanco Animal Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Biohaven	N/A	N/A	-$408.17M	-$9.36	-1.79
Elanco Animal Health	$4.43B	1.60	-$1.23B	$0.74	19.30

Do analysts recommend BHVN or ELAN?

Biohaven presently has a consensus target price of $59.46, suggesting a potential upside of 254.42%. Elanco Animal Health has a consensus target price of $15.17, suggesting a potential upside of 6.19%. Given Biohaven's stronger consensus rating and higher probable upside, research analysts plainly believe Biohaven is more favorable than Elanco Animal Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Biohaven	0 Sell rating(s)	1 Hold rating(s)	12 Buy rating(s)	2 Strong Buy rating(s)	3.07
Elanco Animal Health	0 Sell rating(s)	4 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.43

Which has more risk & volatility, BHVN or ELAN?

Biohaven has a beta of 0.95, meaning that its share price is 5% less volatile than the S&P 500. Comparatively, Elanco Animal Health has a beta of 1.67, meaning that its share price is 67% more volatile than the S&P 500.

Do insiders & institutionals have more ownership in BHVN or ELAN?

88.8% of Biohaven shares are owned by institutional investors. Comparatively, 97.5% of Elanco Animal Health shares are owned by institutional investors. 16.0% of Biohaven shares are owned by company insiders. Comparatively, 0.9% of Elanco Animal Health shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Summary

Biohaven and Elanco Animal Health tied by winning 9 of the 18 factors compared between the two stocks.